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Background: Elevated serum ferritin levels have been reported to contribute to metabolic syndrome (MetS). We
examined the association of serum ferritin levels with the development of MetS in a representative sample of
Chinese male adult population.
Method: The data came from the 2009–2013 Fangchenggang Area Males Health and Examination Survey (FAMHES). We
combined a cross-sectional study of 2417 males and a longitudinal study of 857 males who participated in the FAMHES.
Result: The serum ferritin level of MetS was higher than that of nonMetS (median and percentiles 25–75: 447.4
(294.1-612.4) vs. 302.4 (215.0-435.8) ng/ml, p < 0.01). A positive correlation between ferritin concentrations and
blood pressure (Systolic BP: R = 0.110, Diastolic BP: R = 0.158), waist circumference (R = 0.333), fasting glucose
(R = 0.089), triglyceride (R = 0.315) and low high-density lipoprotein cholesterol (R = 0.130) was significant (all p < 0.001).
Compared with the level of ferritin in the group with no MetS component, the group with all five MetS components
had a higher ferritin level (554.7 (340.1-606.4) vs. 274.2 (198.2-384.4) ng/ml). The odd radio (OR) was higher for MetS in
the highest ferritin quartile (OR = 2.29, 95% CI = 1.47-3.54) compared with the lowest ferritin quartile after adjustment
for multi-factors. After 4-year follow up, 79 subjects newly diagnosed with MetS in 857 cohort male participants in 2013.
Compared with the lowest ferritin quartile, the RR of the highest ferritin quartile was 2.55 (95% CI = 1.30-5.00) after
multiple adjustments (p < 0.01).
Conclusion: Our findings confirm that the serum ferritin level is associated with the independent components of MetS,
and elevated ferritin level is an independent risk factor for MetS development in the Chinese male population during
the 4-year follow-up period.
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Metabolic Syndrome (MetS) is a series of metabolic ab-
normalities, whose clinical features are based on central
obesity, insulin resistance, hypertension, high triglycer-
ides, low high-density lipoprotein cholesterol (HDL),
and the decline of glucose tolerance or type 2 diabetes* Correspondence: yxbo21021@163.com
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unless otherwise stated.mellitus [1]. There is much information indicating that
each abnormality involved in the MetS can increase the
morbidity and mortality of cardiovascular diseases and
cancers [2-4]. From the studies of investigating factors
associated with MetS, we have known that multiple fac-
tors, such as high uric acid level and inflammatory cyto-
kines, are closely associated with MetS [5,6]. Although
the etiology of MetS and the mechanism researches have
made great progress, further research is still necessary
because of their complexity.
Serum ferritin is a kind of storage of iron in the body
tissue soluble protein, which is widely used as a proxyhis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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dividuals [7]. Body iron is a strong pro-oxidant which
causes oxidative tissue damage by catalyzing the forma-
tion of free radicals of several cellular reactions [8-10].
Oxidative stress was indicated to regulate ferritin
mRNA, protein level and its secretion [11,12]. Excessive
accumulation of serum ferritin can lead to pathological
change in the liver [13], circulatory [14] and musculo-
skeletal system [15].
Besides, increasing serum ferritin level plays an im-
portant role in metabolic risk factors such as type 2 dia-
betes [16], insulin resistance [17], hypertension [18], and
dyslipidemia [19,20]. Increasing evidence showed that el-
evated serum ferritin is associated with MetS [21]. A
study proposed by Abril-Ulloa indicated an observation
that there was a higher prevalence of MetS among par-
ticipants with higher ferritin level [22]. However, the
exact molecular mechanism of the relationship between
serum ferritin level and MetS remains unclear.
To our knowledge, there was no prospective study on
the relationship between the serum ferritin level at base-
line and the development of MetS in China so far. Add-
itionally, in our previous studies from Fangchenggang
[23], a coastal city in the southwest of China, we found
that the average serum ferritin level was more than twice
as that of other places in China [24], also America [25]
and Korea [26]. It is unknown whether abnormally high
ferritin concentrations are associated with MetS or not.
Accordingly, we carried out a cross-sectional and longi-
tudinal study to evaluate the temporal relationship be-




A population-based study, which is called the Fangchenggang
Area Males Health and Examination Survey (FAMHES)
among Chinese males aged from 17–88 years in
Guangxi, was designed to investigate the effects of en-
vironment, genetic factors and their interaction on the
development of age-related chronic diseases [27]. All
participants provided written informed consents, and
the study was approved by the Ethics and Human Sub-
ject Committee of Guangxi Medical University.
The cross-sectional study was carried out among 4303
participants who completed a large-scale comprehensive
demographic survey by a face-to-face interview and pro-
fessional health physical examination by trained physi-
cians at the Medical Centre of Fangchenggang First
People’s Hospital between September 2009 and December
2009. Of the 4303 candidates, we excluded participants
who met following criteria: [1] missing serum ferritin re-
sult, [2] having haemochromatosis caused by the abnormal
high level of serum ferritin, [3] knowing a past history ofmalignancy, liver disease, nephropathy, dyslipidemia or/
and thyroid parafunction, [4] alcohol intake 12 h before
physical examination. In the end, 2417 unrelated partici-
pants (56.17%) aged 20–73 years old were enrolled into
the cross-sectional study.
Based on the cross-sectional study, we excluded par-
ticipants who met following criteria: [1] diagnosed as
baseline MetS, [2] missing communication, [3] unwill-
ingness or having some diseases unsuited to participate
in the follow-up, 1109 participants (45.88%) were se-
lected into the longitudinal study, and the follow-up dur-
ation is 4 years.
Data collection and definitions
The data of this study were collected through using a
standardized questionnaire, which included demographic
characteristics (age, ethnicity, occupation, education,
etc.), lifestyle characteristics (smoking status, alcohol in-
take, physical activity, etc.), health status, and medical
history, according to a face-to-face interview by trained
physicians. Smoking status was classified: when the his-
tory of smoking arrived at even more than six months, it
was defined as a smoker, otherwise, it was called non-
smoker. Alcohol drinking was defined as ethanol intake
once or more each week [28]. Participants who did
sports two hours or more than it per week were consid-
ered have physical activity [29]. Family history of chronic
diseases was defined the participants’ parents or siblings
had a history of one of the following diseases: hyperten-
sion, type 2 diabetes mellitus, coronary heart disease or
stroke [27]. Waist circumference was measured the par-
ticipant’s natural waist. Blood pressure was measured by
using a mercury sphygmomanometer on the right aim of
participants who took a 5 minutes rest before measure-
ment according to the world health without shoes by
trained nurses. Then, body mass index (BMI) was calcu-
lated by the body weight (Kg) divided by the square of
height (m2).
Clinical and laboratory measurements
The blood specimens used for biochemical analysis came
from the participants who had been told on an empty
stomach before drawing blood in the physical examination
department of Fangchenggang First People’s Hospital.
Afterwards, the frozen blood samples which had been cen-
trifuged 20-25minutes and stored at 80 degrees below zero
until analysis were transported to the First Affiliated
Hospital of Guangxi Medical University clinical labora-
tory in Nanning within two hours. And the data of tri-
glyceride, high-density lipoprotein, and serum glucose
were collected by using Dimension-Rex Chemistry
Analyzer (Dade Behring) to analysis in the Clinical labora-
tory of Fangchenggang First People’s Hospital. Besides, the
serum ferritin was measured by electrochemiluminescence
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module) immunoassay analyzer (Roche Diagnostics, GmbH,
Mannheim, Germany) with the same batch of reagents.
Definition of MetS cases
The MetS was defined based upon the updated National
Cholesterol Education Program Adult Treatment Panel III
for Asian Americans [30] as having arbitrarily three or
more components in following:[1] waist circumference
reach 90 cm or more, [2] triglyceride at least 1.7 mmol/L,
[3] HDL under 1.03 mmol/L, [4] blood pressure at least
130 mmHg in systolic blood pressure/85 mmHg in diastolic
blood pressure or current use of hypotensive drugs or hav-
ing the history of hypertension, [5] fasting glucose attain
5.6 mmol/l or previously diagnosed with type 2 diabetes
mellitus or taking medications to control hyperglycaemia.
Statistical analysis
The data of the study came from 2417 individuals aged
18–63 years medians (interquartile range) for continu-
ous variables, counts (percentages) for categorical vari-
ables in the baseline data. Mann–Whitney U test of
nonparametric test was used to continuous variables and
x2 test to compare categorical variables. Spearman cor-
relation was used to analyze the correlation coefficient
between serum ferritin and individual components of
the metabolic syndrome. Unadjusted as well as adjusted
odds radio (ORs) and 95% confidence interval (95% CI)
for metabolic syndrome and its components in the quar-
tile group of serum ferritin were calculated by BinaryFigure 1 Distribution of ferritin levels according to the numbers of co
the number of MetS components increased in groups (p < 0.001).The barslogistic regression models. The ORs calculations were
age, smoking status, alcohol stake, family history of
chronic diseases, and physical activity. The x2 statistic
was used to obtain the probability value for the trend in
Figure 1. Binary logistic regression model was also used
to compute relative risks (RRs) and 95%Cl for MetS ac-
cording to quartiles of serum ferritin. Statistical analyses
were performed by SPSS 16.0 for windows, all tests were
two-sided, and statistical significance was set to p < 0.05.
Results
Selection of study participants
Figure 2 shows the flowchart for participants’ selection
of the study. 2417 eligible male subjects were recruited,
including 307 participants with MetS and 2110 partici-
pants without MetS (nonMetS). Among the 2417 sub-
jects, 1109 subjects were selected in cohort study. 93
participants lost follow-up in 2013 were excluded in the
cohort study. Following on a quadrennial basis for
4 years using a protocol similar to the initial examin-
ation, 177 subjects missed record in anthropometric
measurements and clinical biochemistry assays. Eventu-
ally, 839 participants were enrolled for final cohort study
analysis and observed for the development of MetS.
General characteristics in cross-sectional survey
Table 1 shows the demographic, clinical and laboratory
characteristics of 2417 participants. Data are presented
for 307 subjects with MetS and 2110 without MetS
(nonMetS), and the incidence of MetS in 2009 is 12.70%.mponents of the MetS. The ferritin level had a growing trend when
represent median, 25th, and 75th percentile of ferritin.
Figure 2 Flow chart for selection of study participants. Based on the inclusion criteria, 2417 male participated in the cross-sectional study
and 1009 male participated in the cohort study.
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than that of the nonMetS group (median and percentiles
25–75: 447.4 (294.1-612.4) vs. 302.4 (215.0-435.8) ng/ml,
p < 0.01). Besides, compared with nonMetS group, MetS
group had higher median age, blood arterial pressure,
waist circumference, triglyceride, glucose, BMI, and lower
HDL (all p < 0.01). However, no association was found be-
tween MetS and smoking consumption (p = 0. 08), phys-
ical activity (p = 0. 10).Table 1 General characteristics of study population stratified
Total
No. of subjects 2417
Age (years) 36(29–44)
Ferritin (ng/mL) 316.8(221.4-459.9)
SBP (mm Hg) 120(110–126)
DBP (mm Hg) 78(70–80)





Smoking status, yes, n (%) 1248(51.6%)
Alcohol drinking, yes, n (%) 972(40.2%)
Physical activity, yes, n (%) 618(25.6%)
Family history of chronic disease, yes, n (%) 485(20.1%)
Data are presented as median (25 percenile, 75 percentile) or counts (percent).
The Chi-square test for categorical variables and The Mann-Whitrey U test for conti
SBP, systolic blood pressure; DBP, diastolic blood pressure; HDL, high density lipoprCorrelation coefficients between ferritin and metabolic
risk parameters
Spearman correlation coefficients were revealed ferritin
and individual components of MetS, age and BMI in
Table 2. There is a significant positive correlation be-
tween ferritin and SBP, DBP, waist circumference, trigly-
ceride, glucose, low HDL, age, and BMI (all p < 0.001).
The strongest correlation (R = 0. 333) was shown be-

















otein cholesterol; BMI, body mass index; MetS, metabolic syndrome.
Table 2 Spearman correlation coefficients between
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components and a higher level of ferritin was indicated
in Figure 1. The groups with 0, 1, 2, 3, 4, 5 of MetS com-
ponents had 985, 705, 420, 218, 78, 11 subjects and
274.2, 320.9, 347.9, 427.5, 497.7, 554.7 ng/ml of median
ferritin level respectively.Association between serum ferritin concentrations and
MetS and its individual components
As shown in Table 3, increasing ORs for MetS were ob-
served from 1st to 4th ferritin quartiles by binary logistic
regression. Compared with the lowest quartile of ferritin
(1st Q), the ORs and 95% CI of MetS with respect to 2nd Q,
3rd Q, 4th Q were 1.48 (0.95-2.29), 2.08 (1.37-3.16), 5.12
(3.48-7.52) respectively in the unadjusted analyses. After
adjusting for age, the ORs and 95% CI of MetS with respect
to 2nd Q, 3rd Q, 4th Q were 1.61 (1.03-2.52), 2.21 (1.44-
3.37), 5.08 (3.44-7.50) respectively in model 1. The ORs
and 95% CI of MetS with respect to 2nd Q, 3rd Q, 4th Q
were 1.59 (1.01-2.48), 2.11 (1.37-3.22), 4.90 (3.31-7.26) re-
spectively in model 2, plus model 1 and adjusted physical
activity, family history of chronic diseases (4 covariate:
hypertension, diabetes mellitus, stroke, coronary heart dis-
ease), lifestyle factor of alcohol drinking status and smoking
status. The ORs and 95% CI of MetS with respect to 2nd Q,
3rd Q, 4th Q were 1.20 (0.77-2.08), 1.32 (0.83-2.12), 2.29Table 3 Odd radios and 95% confidence interval of metabolic
logistic regression
Ferritin Cases (%) Unadjusted p1 Model 1
1st Q 36(5.97%) Ref Ref
2nd Q 52(8.60%) 1.48(0.92-2.29) 0.08 1.61(1.03-2.52)
3rd Q 71(11.72%) 2.08(1.37-3.16) <0.01 2.21(1.44-3.37)
4th Q 148(24.54%) 5.12(3.48-7.52) <0.01 5.08(3.44-7.50)
Ptrend <0.01 <0.01
1st Q: <221.4 ng/ml; 2nd Q: 221.4-318.7 ng/ml; 3rd Q: 318.8-459.9 ng/ml; 4th Q: >45
Model 1,Odds radio adjusted for age, model 2 plus model 1 and physical activity, fa
stoke, coronary heart disease), lifestyle factor of alcohol drinking status and smokin(1.47-3.54) respectively in model 3, plus model 2 and fur-
ther adjusted BMI.
What’s more, Figure 3 provides the association of fer-
ritin and individual components of MetS. These analyses
adjusted age, BMI, physical activity, family history of
chronic diseases (4 covariate: hypertension, diabetes
mellitus, stroke, coronary heart disease), lifestyle factor
of alcohol drinking status and smoking status. Compared
with the lowest ferritin quartile, the ORs and 95% CI of
waist circumference, triglyceride, HDL in the highest
ferritin quartile were significant 2.04 (1.19-3.49), 2.40
(1.78-3.22), 2.15 (1.28-3.61), respectively.
Baseline characteristics in cohort study
857 participants followed up for 4 years were selected
from 2110 nonMetS in 2009 (Table 4). 18 missed life-
style questionnaire or lacked the data of diagnosing
MetS. Data are presented for 79 subjects with MetS and
760 without MetS, and the new incidence of MetS in
2013 is 9.42%. The ferritin level of MetS group was obvi-
ously higher than that of the nonMetS group (357.1
(260.0-526.1) vs. 293.4 (208.4-417.0) ng/ml, p < 0.01).
Besides, MetS subjects had higher age, blood arterial
pressure, waist circumference, triglyceride, glucose,
BMI, and lower HDL than no MetS subjects (all p < 0.01).
However, no association was found between MetS and
smoking consumption, physical activity.
Association between serum ferritin concentrations and
the incidence of the MetS after a 4-year follow up
In the final analyses (Table 5), compared with the lowest
quartile of ferritin, in the unadjusted analyses, the RR of
MetS in the highest ferritin quartile was 2.50 (1.28-4.88)
(p = 0. 07). Furthermore, model 1 adjusted age, the RR of
MetS in the highest ferritin quartile was 2.58 (1.32-5.05)
(p < 0.01). Eventually, model 2 adjusted physical activity,
family history of chronic diseases (4 covariate: hyperten-
sion, diabetes mellitus, stroke, coronary heart disease),
lifestyle factor of alcohol drinking status and smoking
status, the RR of MetS in the highest ferritin quartile
was 2.55 (1.30-5.00) (p < 0.01).syndrome according to quartiles of ferritin: a binary
OR (95% CI)
p2 Model 2 p3 Model 3 p4
Ref Ref
0.04 1.59(1.01-2.48) 0.04 1.27(0.77-2.08) 0.35
<0.01 2.11(1.37-3.22) <0.01 1.32(0.83-2.12) 0.25
<0.01 4.90(3.31-7.26) <0.01 2.29(1.47-3.54) <0.01
<0.01 <0.01
9.9 ng/ml.
mily history of chronic diseases(4 covariates: hypertension, diabetes mellitus,
g status. model 3 further BMI.
Figure 3 Multiple adjusted odds radio and 95% CI of individual components of MetS according to quartile of ferritin. The OR values
increased with increasing quartile group of serum ferritin concentrations in waist circumference, triglycerides, and low HDL (all p < 0.01). The
serum ferritin level was associated with MetS components adjusting age, BMI, smoking status, alcohol stake, family history of chronic diseases.
Table 4 Baseline characteristics of study population stratified for the MetS and non-MetS in 2013
Total MetS Non-MetS p
No. of subjects 839 79 760
Age (years) 37(30–45) 40(35–45) 37(29–45) 0.01
Ferritin (ng/mL) 301.1(210.9-426.6) 357.1 (260.0-526.1) 293.4(208.4-417.0) <0.01
SBP (mm Hg) 117(108–124) 120(110–126) 116(108–124) <0.01
DBP (mm Hg) 78(70–80) 80(74–84) 76(70–80) <0.01
Waist circumference (cm) 79.1(72.5-85.3) 87.0(82.8-90.4) 78.0(72.0-84.2) <0.01
Triglyceride (mmol/L) 1.01(0.72-1.46) 1.52(1.29-2.06) 0.95(0.69-1.38) <0.01
Glucose (mmol/L) 5.1(4.8-5.5) 5.3(5.0-5.6) 5.1(4.8-5.4) <0.01
HDL (mmol/L) 1.40(1.22-1.61) 1.21(1.11-1.32) 1.41(1.24-1.63) <0.01
BMI (kg/m2) 22.71(20.61-24.71) 25.46(23.74-27.27) 22.40(20.43-24.25) <0.01
Smoking status, yes, n (%) 0.35
Smoking 404(48.2%) 42(53.2%) 362(47.6%)
Non-smoking 435(51.8%) 37(46.8%) 398(52.4%)
Alcohol drinking, yes, n (%) 337(40.2%) 31(39.2%) 306(40.3%) 0.86
Physical activity, yes, n (%) 185(22.1%) 23(29.1%) 162(21.3%) 0.11
Family history of chronic disease, yes, n (%) 156(18.6%) 16(20.3%) 140(18.4%) 0.69
Data are presented as median (25 percenile, 75 percentile) or counts (percent).
The Chi-square test for categorical variables and The Mann-Whitrey U test for continuous variables.
SBP, systolic blood pressure; DBP, diastolic blood pressure; HDL, high density lipoprotein cholesterol; BMI, body mass index; MetS, metabolic syndrome.
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Table 5 RRs and 95% CI for the incidence of the MetS according to quartiles of ferritin level after 4-year follow-up
RR (95% CI)
Ferritin Cases (%) Unadjusted p1 Model 1 p2 Model 2 p3
1st Q 12(5.74%) ref ref ref
2nd Q 15(7.14%) 1.26(0.58-2.77) 0.56 1.36(0.62-2.99) 0.45 1.33(0.60-2.95) 0.48
3rd Q 22(10.43%) 1.91(0.92-3.97) 0.08 2.03(0.97-4.24) 0.06 2.01(0.96-4.22) 0.07
4th Q 30(14.35%) 2.75(1.37-5.54) <0.01 2.87(1.42-5.79) <0.01 2.84(1.40-5.75) <0.01
Ptrend <0.01 <0.01 <0.01
1st Q: <210.9 ng/ml; 2nd Q: 210.9-301.0 ng/ml; 3rd Q: 301.1-426.6 ng/ml; 4th Q: >426.6 ng/ml.
model 1 were adjusted age, model 2 further adjusted smoking status, alcohol drinking status, family history of chronic disease, physical activity.
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In our study, the data was observed an evident correl-
ation between serum ferritin concentrations and the in-
dependent components of MetS. Blood pressure, waist
circumference, fasting glucose, triglyceride, low HDL,
age, and BMI were positively correlated with ferritin
concentrations. What’s more, waist circumference and
triglycerides were the best correlates of serum ferritin,
and this suggested high ferritin concentrations may re-
flect hypertriglyceridemic phenotype which was pre-
dicted in women by low lipoprotein(a) levels [31].
Besides, the median of ferritin level had a growing
trend when the number of MetS components increased
in groups. Similarly, a previous study by Jiang Li et al.
had reported that with the higher ferritin level quartile,
the higher percentage of participants with MetS or its
components [32]. In addition, several studies have re-
ported the association between serum ferritin concentra-
tions and MetS diagnostic components. In accordance
with a 5-year prospective cohort in Korean men [33], we
also found it had no appreciable effect on the relation-
ship between serum ferritin level and waist circumfer-
ence after adjusted for BMI. A report by Mateo-Gallego
et al. has shown the serum ferritin level is a major deter-
minant of hypertriglyceridemia in individuals with
familial-type dyslipidemia [34]. Our results support the
supposition that serum ferritin level is correlated with
increasing triglyceride concentrations in Chinese males.
The same result also shows on the association between
ferritin level and HDL.
Sung Keun Park et al. found a longitudinal relationship
between serum ferritin and the development of MetS in
13084 Korean males from a 5–year follow-up study [26].
Our results are in line with cross-sectional study and
also extend these observations to examine the prospect-
ive association between baseline ferritin level and the de-
velopment of MetS over a 4-year follow-up study. In our
study, we found that the highest quartile of ferritin level
had significant relationship with the development of
MetS, and the risk of MetS increased with increasing
quartile group of serum ferritin concentrations. How-
ever, we could not reach the level of a significant resultafter adjustment for BMI, and It maybe there were
strong associations between BMI and the complements
of MetS, such as waist circumference.
Interestingly, although the ferritin concentrations of
participants are higher than that in previous studies, the
incidence of MetS in the study in 2009 was 12.70%,
which was similar to that in Chinese mainland in 2004
(13.7%). Jung-Su Chang reported the incidence of MetS
was 43.1% in a 1260 Taiwanese men study where the
mean of ferritin level is 229 (±349) ng/ml [35]. Taiwan is
a sea island, and the age distribution of male and female
participant trend towards middle-aged (mean and stand-
ard deviation: 54.3 ± 17.8 yrs old) in the study. However,
the age distribution of our participants is skewed distri-
bution which mainly concentrated in the young stage
(median and percentiles 25–75: 36 (29–44) yrs old). That
may indicate the MetS incidence increases with age.
Environmental factors and genotype could make an
approximately equal contribution to the body iron status
[36], and serum ferritin level differs visibly according to
age, gender, geographic location, and ethnicity [37,38].
Harris and colleagues found Asian men and women
have higher adjusted mean serum ferritin concentra-
tions compared with their white counterparts [39].
Fangchenggang is a littoral city in which diet and life-
style are different from the inland and island. Long-
time constant diet or lifestyle in causing the increase of
serum ferritin level may lead to some changes of serum
ferritin level and its mechanism in the body as well.
Moreover, after 4-year follow-up period, we found that
the highest level of ferritin was associated in 2.55-fold
to the development of MetS. There were 79 partici-
pants new suffering MetS, from 857 which were se-
lected out from 2417 nonMetS in 2009, and we
couldn’t get a comprehensive result because of selec-
tion bias. The follow-up participants had a younger age
distribution, and they were randomly selected from
nonMetS participants in 2009, so the risk of suffering
MetS was smaller. However, the incidence of MetS was
9.42%, which indicated MetS is rapidly developing in
Fangchegngang. It’s prominent that we should pay
more attention on the prevention of MetS.
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Nevertheless, when interpreting the findings of the
current work, some limitations should be considered.
Firstly, the female subjects were not included in the par-
ticipants in our study, and our results may lack of
enough persuasion and not be extrapolated to females.
Secondly, we couldn’t analyze comprehensively the asso-
ciation of serum ferritin and MetS, due to lack of other
iron-related markers such as trans-ferritin and total
iron-binding capacity as a marker of body iron status.
Thirdly, the information for dietary intake is not con-
cluded, which may influence body iron stores.
Conclusions
Our findings have explicitly shown that the elevated fer-
ritin level is an important independent risk factor for the
development of MetS in the littoral Chinese male popu-
lation. Serum ferritin level may become a new guidance
of the early prevention of MetS. However, the molecule
mechanism of ferritin playing in the development
process of MetS is still unclear and it needs further re-
search to explore.
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